GIOTTA GREGORY J 4
4 · ONYX PHARMACEUTICALS INC · Filed Sep 8, 2004
Insider Transaction Report
Form 4
GIOTTA GREGORY J
VP & Chief Legal Counsel
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2004-09-07−4,896→ 19,979 totalExercise: $5.00From: 2003-08-12Exp: 2013-02-11→ Common Stock (4,896 underlying) - Sale
Common Stock
2004-09-07$40.81/sh−974$39,749→ 9,026 total - Exercise/Conversion
Common Stock
2004-09-07$4.87/sh+2,500$12,175→ 2,500 total - Sale
Common Stock
2004-09-07$41.03/sh−5,400$221,562→ 0 total - Exercise/Conversion
Common Stock
2004-09-07$5.00/sh+4,896$24,480→ 10,000 total - Disposition to Issuer
Stock Option (Right to Buy)
2004-09-07−2,604→ 11,979 totalExercise: $4.00From: 2003-01-22Exp: 2012-07-21→ Common Stock (2,604 underlying) - Exercise/Conversion
Common Stock
2004-09-07$4.00/sh+2,604$10,416→ 5,104 total - Sale
Common Stock
2004-09-07$41.00/sh−3,626$148,666→ 5,400 total - Disposition to Issuer
Stock Option (Right to Buy)
2004-09-07−2,500→ 5,833 totalExercise: $4.87From: 2002-06-06Exp: 2011-11-05→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option become exercisable at a rate of 12.5% on the date 6 months following the date of grant and in equal monthly installments thereafter for the following 42 months.